NEM vs PYXS · P/E 14, rev $13.43B vs rev $2.8M
Newmont Goldcorp Corp (NEM) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
NEM currently screens at market cap $112.81B and trailing P/E 13.7. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the NEM and PYXS stock pages for the full models.
Not investment advice.